Pursue Wealth Partners’s Ascendis Pharma A/S ASND Stock Holding History

Pursue Wealth Partners’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$332K	Hold	1,451	–	–	0.2%	74
2025 Q4	$309K	Hold	1,451	–	–	0.15%	79
2025 Q3	$288K	Hold	1,451	–	–	0.16%	89
2025 Q2	$250K	Hold	1,451	–	–	0.14%	100
2025 Q1	$226K	Buy	+1,451	New	+$207K	0.14%	108
2024 Q4	–	Sell	-1,451	Closed	-$217K	–	117
2024 Q3	$217K	Buy	+1,451	New	+$196K	0.12%	104
2024 Q2	–	Sell	-1,451	Closed	-$219K	–	113
2024 Q1	$219K	Buy	+1,451	New	+$207K	0.13%	96
2022 Q2	–	Sell	-1,451	Closed	-$166K	–	125
2022 Q1	$166K	Buy	+1,451	New	+$168K	0.07%	140

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Pursue Wealth Partners's ASND Position: Q1 2026 in Review

Pursue Wealth Partners held its Ascendis Pharma A/S (ASND) position steady in Q1 2026 at 1,451 shares worth $332K. The position accounts for 0.2% of the portfolio, ranked #74.

Pursue Wealth Partners first reported a position in ASND in Q1 2022 and has held it in 8 quarters since. 273 funds tracked by Wall St. Rank hold ASND as of Q1 2026.

Pursue Wealth Partners held 1,451 shares of Ascendis Pharma A/S worth $332K as of Q1 2026.
Pursue Wealth Partners left its Ascendis Pharma A/S share count unchanged in Q1 2026.
Ascendis Pharma A/S made up 0.2% of Pursue Wealth Partners's portfolio in Q1 2026, its #74 holding.
Pursue Wealth Partners first reported a position in Ascendis Pharma A/S in Q1 2022 and has held it in 8 quarters since.
273 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q1 2026.

Based on Pursue Wealth Partners's 13F filing for Q1 2026, filed 8 Apr 2026.